title: Behavioral consequences of delta-opioid receptor activation in the periaqueductal gray of morphine tolerant rats.
abstract: Chronic morphine administration shifts delta-opioid receptors (DORs) from the cytoplasm to the plasma membrane. Given that microinjection of morphine into the PAG produces antinociception, it is hypothesized that the movement of DORs to the membrane will allow antinociception to the DOR agonist deltorphin II as a way to compensate for morphine tolerance. Tolerance was induced by twice daily injections of morphine (5, 10, or 20 mg/kg, subcutaneous) for 3.5 days. Microinjection of deltorphin into the vPAG 6 hours after the last morphine injection produced a mild antinociception that did not vary in a consistent manner across morphine pretreatment doses or nociceptive tests. In contrast, deltorphin caused a decrease in activity in morphine tolerant rats that was associated with lying in the cage. The decrease in activity and change in behavior indicate that chronic morphine administration alters DORs in the vPAG. However, activation of these receptors does not appear to compensate for the decrease in antinociception caused by morphine tolerance.
authors.affiliation: Department of Psychology, Washington State University Vancouver, Vancouver, WA 98686, USA. morgan@vancouver.wsu.edu
authors.forename: Michael M
authors.initials: MM
authors.lastname: Morgan
authors.forename: Michelle D
authors.initials: MD
authors.lastname: Ashley
authors.forename: Susan L
authors.initials: SL
authors.lastname: Ingram
authors.forename: MacDonald J
authors.initials: MJ
authors.lastname: Christie
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D002404:Catheterization; D002462:Cell Membrane / Q000378:metabolism; D004361:Drug Tolerance / Q000502:physiology; D008297:Male; D008845:Microinjections; D009020:Morphine / Q000008:administration & dosage*; D009043:Motor Activity / Q000187:drug effects; D009474:Neurons / Q000378:metabolism; D009842:Oligopeptides / Q000008:administration & dosage; D010147:Pain Measurement; D017288:Pain Threshold / Q000187:drug effects*; D010487:Periaqueductal Gray / Q000187:drug effects* / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D017465:Receptors, Opioid, delta / Q000819:agonists / Q000378:metabolism*
chemical_list: D009842:Oligopeptides; D017465:Receptors, Opioid, delta; C060209:deltorphin II, Ala(2)-; D009020:Morphine